NG

Neeraj Gupta

Director Director DIN 08545851
DIN 08545851 First appointment Dec 2000 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2000
Shareholding value β€’β€’β€’β€’ Premium profile

About Neeraj Gupta

Data last updated:

Neeraj Gupta was a Director at Multi Pharma Private Limited (2000–2015) and Designated Partner at Eat N Shine Elements Llp (from 2019). The companies operate in Pharma.

DIN 08545851
Primary Designation Director
Industry Pharma
First Appointment 20 Dec 2000
Oldest Company Age 7 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Multi Pharma Private Limited U74899DL2000PTC108952
Director20 Dec 20002000₹11.5 Lakh (FY 2025)Active
Designated Partner26 Aug 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eat N Shine Elements Llp
Multi Pharma Private Limited
Premium access

Shareholding and investment profile for Neeraj Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Gupta

Neeraj Gupta was first appointed on 20 Dec 2000 as Director at Multi Pharma Private Limited. The most recent appointment on record is 26 Aug 2019 at Eat N Shine Elements Llp.

Neeraj Gupta held 2 earlier board appointments: Multi Pharma Private Limited (Director, 20 Dec 2000 to 01 Nov 2015); Eat N Shine Elements Llp (Designated Partner, from 26 Aug 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available